Recent Series H funding at a $965 billion post-money valuation in May 2026, followed by a confidential IPO filing on June 1, has centered trader expectations around a fall 2026 listing for Anthropic's Claude large language model business. Strong annualized revenue growth toward $47 billion and enterprise adoption differentiate the company from OpenAI amid intensifying AI competition, though public market discipline after comparable tech debuts tempers enthusiasm for the $2 trillion-plus targets cited by some backers. Closely matched probabilities between the $1.25–1.50 trillion and $1.50–1.75 trillion bands reflect uncertainty over exact pricing multiples relative to forward revenue and regulatory or competitive shifts before resolution.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено$1.50–$1.75T 44%
$1.25–$1.50T 43%
<$1.25T 41%
$1.75–$2.00T 34%
<$1.25T
41%
$1.25–$1.50T
43%
$1.50–$1.75T
44%
$1.75–$2.00T
34%
$2.00–$2.25T
13%
$2.25–$2.50T
8%
$2.50T+
9%
No IPO by December 31, 2027
6%
$1.50–$1.75T 44%
$1.25–$1.50T 43%
<$1.25T 41%
$1.75–$2.00T 34%
<$1.25T
41%
$1.25–$1.50T
43%
$1.50–$1.75T
44%
$1.75–$2.00T
34%
$2.00–$2.25T
13%
$2.25–$2.50T
8%
$2.50T+
9%
No IPO by December 31, 2027
6%
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Открытие рынка: Aug 19, 2026, 9:45 AM ET
Resolver
0x69c47De9D...The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Resolver
0x69c47De9D...Recent Series H funding at a $965 billion post-money valuation in May 2026, followed by a confidential IPO filing on June 1, has centered trader expectations around a fall 2026 listing for Anthropic's Claude large language model business. Strong annualized revenue growth toward $47 billion and enterprise adoption differentiate the company from OpenAI amid intensifying AI competition, though public market discipline after comparable tech debuts tempers enthusiasm for the $2 trillion-plus targets cited by some backers. Closely matched probabilities between the $1.25–1.50 trillion and $1.50–1.75 trillion bands reflect uncertainty over exact pricing multiples relative to forward revenue and regulatory or competitive shifts before resolution.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы